1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors

SOHO 2026 Annual Meeting

September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas

Posters by Code

Showing 1,267 results.

AML - 172

Insurance Status and In-Hospital Outcomes Among Adults With Acute Leukemia: A Nationwide Analysis (2016-2021)

Aditi Parulkar

Poster Presenter: Aditi Parulkar

Thumbnail for Disseminated Extranodal Diffuse Large B-Cell Lymphoma With Genitourinary and Extensive Osseous Involvement Mimicking Metastatic Solid Malignancy

ABCL - 174

Disseminated Extranodal Diffuse Large B-Cell Lymphoma With Genitourinary and Extensive Osseous Involvement Mimicking Metastatic Solid Malignancy

Ghada Elgohary

Poster Presenter: Ghada Elgohary

Thumbnail for Persistent Age and Regional Disparities in Sepsis-Associated Mortality Among Acute Myeloid Leukemia Patients: Limited Impact of Modern Therapies on Equity in Outcomes: A US Population-Based Analysis (2000-2023)

AML - 175

Persistent Age and Regional Disparities in Sepsis-Associated Mortality Among Acute Myeloid Leukemia Patients: Limited Impact of Modern Therapies on Equity in Outcomes: A US Population-Based Analysis (2000-2023)

Tapan Giri

Poster Presenter: Tapan Giri

CT - 177

Outcomes of Allogeneic HSCT in Patients With Paroxysmal Nocturnal Hemoglobinuria in Resource-Constrained Settings

Khadija Bano

Poster Presenter: Khadija Bano

$Thumbnail for Clinical Outcomes Among Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Zanubrutinib or Acalabrutinib in Real-World Practice in the United States$

MCL - 178

Clinical Outcomes Among Patients With Relapsed/Refractory Mantle Cell Lymphoma Receiving Zanubrutinib or Acalabrutinib in Real-World Practice in the United States

Javier Munoz

Poster Presenter: Javier Munoz

Video

Thumbnail for Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System

CLL - 179

Real-World Pharmacovigilance Assessment of Hematologic Safety Signals Among Bruton Tyrosine Kinase Inhibitors, Including Pirtobrutinib: Insights From the Food and Drug Administration Adverse Event Reporting System

Klesta Cocoli

Poster Presenter: Klesta Cocoli

Thumbnail for Characterizing Patient Self-Reported Adherence to BTKis and Symptoms in CLL/SLL Using an Electronic Patient-Reported Outcomes (ePRO) Platform

CLL - 180

Characterizing Patient Self-Reported Adherence to BTKis and Symptoms in CLL/SLL Using an Electronic Patient-Reported Outcomes (ePRO) Platform

Lee Ding

Poster Presenter: Lee Ding

Thumbnail for Temporal Trends and Pandemic Disruption in Co-Contributing Mortality From Multiple Myeloma and Chronic Ischemic Heart Disease in Older Adults (1999-2024)

MM - 182

Temporal Trends and Pandemic Disruption in Co-Contributing Mortality From Multiple Myeloma and Chronic Ischemic Heart Disease in Older Adults (1999-2024)

Osama Mohiuddin

Poster Presenter: Osama Mohiuddin

Thumbnail for Cardiovascular Cause-of-Death Trends in Chronic Lymphocytic Leukemia in the BTK Inhibitor Era: A Population-Based Competing Risk Analysis (SEER 2005-2022)

CLL - 183

Cardiovascular Cause-of-Death Trends in Chronic Lymphocytic Leukemia in the BTK Inhibitor Era: A Population-Based Competing Risk Analysis (SEER 2005-2022)

Yasir Aziz

Poster Presenter: Yasir Aziz